(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Thymoglobulin: Powder for solution for injection (25mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ANTI-THYMOCYTE IMMUNE GLOBULIN (an tee THI mo cite im MUNE GLOB yoo lin) weakens the body's immune system. This medicine is used to treat kidney transplant rejection.

In-Depth Information

Thymoglobulin 25mg Powder for Injection

NDC: 584680080
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Kidney Transplant Rejection

Sometimes used for but not FDA approved for the following conditions:
Graft-versus-host Disease (GVHD), Heart Transplant Rejection, Heart Transplant Rejection Prophylaxis, Graft-versus-host Disease (GVHD) Prophylaxis, Kidney Transplant Rejection Prophylaxis, Myelodysplastic Syndrome (MDS), Aplastic Anemia, Stem Cell Transplant Preparation

Storage Information
Protect from light
Reconstituted product may be stored at room temperature for up to 24 hours but is not recommended
Reconstituted product should be used immediately. Discard unused portion
Discard unused portion. Do not store for later use.
Refrigerate (between 36 and 46 degrees F)
Protect from freezing
Thymoglobulin 25mg Powder for Injection

Reported Side Effects for Thymoglobulin 25mg Powder for Injection

Hole In Intestines Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Hemolysis Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Infusion-related Reactions Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Vomiting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Intestinal Bleeding Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Fluid In Lungs Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Muscle Pain Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Severe Allergy Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Hemolytic Anemia Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Lyell'S Syndrome Incidence:
0.2%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
0.2%*
Severity: SEVERE
Onset: RAPID
Paresthesias Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Vocal Cord Spasm Incidence:
0.2%*
Severity: SEVERE
Onset: RAPID
Distressed Incidence:
0.4%*
Severity: MILD
Onset: EARLY
Protein In The Urine Incidence:
0.4%*
Severity: MODERATE
Onset: DELAYED
Increased Blood Sugar Incidence:
0.6%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
0.8%*
Severity: SEVERE
Onset: DELAYED
Eosinophilia Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Yeast Infection Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
1.0-50.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cells Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.1%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
1.1-23.0%*
Severity: MODERATE
Onset: RAPID
Shortness Of Breath Incidence:
1.1-28.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
2.7-9.0%*
Severity: MODERATE
Onset: EARLY
Low Blood Pressure Incidence:
2.9-16.0%*
Severity: MODERATE
Onset: RAPID
High Blood Pressure Incidence:
2.9-37.0%*
Severity: MODERATE
Onset: EARLY
Irritated Blood Vessels Incidence:
3.2%*
Severity: MODERATE
Onset: RAPID
Itching Incidence:
4.6-6.0%*
Severity: MILD
Onset: RAPID
Serum Sickness Incidence:
5.0-85.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
5.3-40.0%*
Severity: MILD
Onset: EARLY
Low Phosphate Level Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Low Potassium Levels Incidence:
6.0-12.0%*
Severity: MODERATE
Onset: DELAYED
Diaphoresis Incidence:
6.0-13.0%*
Severity: MILD
Onset: EARLY
High Phosphate Levels Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Nervousness Incidence:
7.0-14.0%*
Severity: MILD
Onset: DELAYED
Hives Incidence:
9.2%*
Severity: MILD
Onset: RAPID
Inability To Sleep Incidence:
12.0-20.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
13.0-25.6%*
Severity: MILD
Onset: EARLY
Increased Blood Fats Incidence:
15.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
23.5-30.5%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
>25.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
>25.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
>25.0%*
Severity: MILD
Onset: EARLY
High Potassium Level Incidence:
27.0-57.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
29.6-57.3%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
36.6-44.4%*
Severity: MODERATE
Onset: DELAYED
Chills Incidence:
43.2-57.3%*
Severity: MILD
Onset: RAPID
Fever Incidence:
63.0%*
Severity: MILD
Onset: EARLY
Antibody Formation Incidence:
68.0-78.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
First Trimester

Class 6 - Unknown Risk

Second Trimester

Class 6 - Unknown Risk

Third Trimester

Class 6 - Unknown Risk

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Thymoglobulin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5